Akela total consolidated revenues increase to $7.3M for six months ended June 30, 2011

Akela Pharma, Inc. ("Akela"), (TSX: AKL) and PharmaForm, a leading specialty contract service provider in the area of pharmaceutical dosage form development and manufacturing, today announced its financial results for the three and six months and year ended June 30, 2011.

Total consolidated revenues for the three months ended June 30, 2011 were $3.1 million, including $2.4 million of contract services, as compared to $3.1 million, including $2.4 million of contract services, for the same period during the previous year. Total consolidated revenues for the six months ended June 30, 2011 were $7.3 million as compared to $5.7 million for the same period in 2010.

Consolidated net income (loss) for the three months ended June 30, 2011 was ($0.52) million, or ($0.02) per share, versus $0.15 million or $0.01 per share, for the same period in 2010. Consolidated net income for the six months ended June 30, 2011 was $0.48 million vs. $0.17 million, for the same period in 2010.

The Company had a cash balance of $0.21 as of June 30, as compared with $0.14 million as of March 31, 2011.

Source:

AKELA PHARMA INC.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Southwest Research Institute breaks ground on new clinical supply facility